Eating well on semaglutide, tirzepatide, and the rest. Independent clinical guidance for patients on GLP-1 receptor agonists.https://glp1nutrition.org/en-usCC BY-NC 4.0https://glp1nutrition.org/apps/comparison-best-app-for-glp1-2026/https://glp1nutrition.org/apps/comparison-best-app-for-glp1-2026/Head-to-head comparison of the eight calorie, macro, and dose-tracking apps reviewed on this site, scored against four GLP-1-specific axes: photo-logging speed for smaller meals, protein-tracking depth, micronutrient coverage under reduced intake, and presence of a built-in GLP-1 workflow.Wed, 15 Apr 2026 00:00:00 GMTbest app for GLP-1GLP-1 tracker comparisonbest GLP-1 calorie tracker 2026PlateLens vs MyNetDiaryCronometer vs PlateLens GLP-1https://glp1nutrition.org/apps/platelens-glp1-review/https://glp1nutrition.org/apps/platelens-glp1-review/PlateLens is a photo-first calorie and macronutrient tracker whose feature set — fast photo logging, independently validated calorie accuracy, deep micronutrient coverage, and wearable integrations — fits the smaller-meal, lean-mass-aware tracking pattern that GLP-1 receptor agonist patients commonly need. Editorial pick on the photo-logging axis.Wed, 08 Apr 2026 00:00:00 GMTPlateLensGLP-1 tracking appGLP-1 calorie trackerGLP-1 protein trackersemaglutide apptirzepatide appWegovy trackingphoto food logginghttps://glp1nutrition.org/medications/medication-comparison-nutritional-impact/https://glp1nutrition.org/medications/medication-comparison-nutritional-impact/Side-by-side comparison of semaglutide, tirzepatide, liraglutide, dulaglutide, and exenatide on the dimensions that matter for nutritional planning. Magnitude of appetite suppression, dose schedule rhythm, side-effect profile, and the practical implications for protein, hydration, and micronutrient planning.Thu, 02 Apr 2026 00:00:00 GMTGLP-1 medication comparisonOzempic vs Wegovy vs Mounjaro nutritionGLP-1 nutritional impactGLP-1 RA comparisonhttps://glp1nutrition.org/apps/cronometer-glp1-review/https://glp1nutrition.org/apps/cronometer-glp1-review/Cronometer is the strongest hand-tracking option for micronutrient depth among the apps reviewed and remains a defensible pick for GLP-1 patients whose primary nutritional risk concern is deficiency tracking and who are willing to log by typing rather than by photo.Mon, 30 Mar 2026 00:00:00 GMTCronometerGLP-1 micronutrientsGLP-1 deficiency trackingCronometer semaglutideCronometer WegovyGLP-1 nutrient gaphttps://glp1nutrition.org/apps/mynetdiary-glp1-review/https://glp1nutrition.org/apps/mynetdiary-glp1-review/MyNetDiary's GLP-1 mode is the most-developed dedicated GLP-1 workflow among the apps reviewed. RD-favored on the dedicated-mode reason, with a dietitian-curated database and a functional free tier. Photo logging and UI design are the main weak points.Sun, 22 Mar 2026 00:00:00 GMTMyNetDiaryMyNetDiary GLP-1GLP-1 dietitian appRD recommended GLP-1 appWegovy appMounjaro appGLP-1 trackerhttps://glp1nutrition.org/research/app-assisted-glp-1-nutrition-evidence/https://glp1nutrition.org/research/app-assisted-glp-1-nutrition-evidence/Published evidence on app-assisted nutrition in GLP-1 patient populations. The Tay et al. 2025 trial of dietitian-supported app-based intervention. The Weiss et al. 2026 head-to-head app-accuracy validation study. What the evidence does and does not support.Sun, 22 Mar 2026 00:00:00 GMTGLP-1 app evidenceGLP-1 calorie tracker researchWegovy app trialGLP-1 nutrition app evidenceapp-assisted weight losshttps://glp1nutrition.org/apps/shotsy-review/https://glp1nutrition.org/apps/shotsy-review/Shotsy is a dedicated GLP-1 dose tracker, not a calorie tracker. Reviewed on its own narrow category. It pairs well with PlateLens, MyNetDiary, or Cronometer for patients who want a clean injection log alongside their nutrition log.Wed, 18 Mar 2026 00:00:00 GMTShotsyGLP-1 dose trackerGLP-1 injection logsemaglutide dose trackerWegovy injection logMounjaro dose trackerhttps://glp1nutrition.org/apps/myfitnesspal-glp1-review/https://glp1nutrition.org/apps/myfitnesspal-glp1-review/MyFitnessPal added a GLP-1 mode in 2025. The app retains the largest food database in the consumer market and is a defensible pick for patients already familiar with MFP, but the GLP-1 mode is a skin on regular MFP rather than a ground-up redesign, and recent paywall changes have weakened the free tier.Sun, 15 Mar 2026 00:00:00 GMTMyFitnessPalMyFitnessPal GLP-1MFP GLP-1 modeGLP-1 calorie counterMFP semaglutideMFP tirzepatidehttps://glp1nutrition.org/medications/compounded-semaglutide-nutrition/https://glp1nutrition.org/medications/compounded-semaglutide-nutrition/GLP-1 Nutrition takes no position on whether compounded semaglutide should be used. This article addresses the nutritional considerations that apply to patients who are using compounded formulations, with explicit reminders that compounded medications are not FDA-approved and that all clinical decisions require involvement of a prescribing clinician.Thu, 12 Mar 2026 00:00:00 GMTcompounded semaglutidecompounded GLP-1 nutritioncompounded semaglutide dietcompounded tirzepatide nutritionhttps://glp1nutrition.org/side-effects/dose-escalation-side-effect-timing/https://glp1nutrition.org/side-effects/dose-escalation-side-effect-timing/What to expect nutritionally at each dose escalation. The standard adjustment pattern (smaller, lower-fat, more frequent meals; structured hydration; protein-first emphasis). When to discuss titration pace with the clinician.Tue, 10 Mar 2026 00:00:00 GMTGLP-1 dose escalationWegovy escalation side effectsOzempic dose increasetirzepatide escalationMounjaro dose increaseGLP-1 titration nutritionhttps://glp1nutrition.org/apps/macrofactor-glp1-review/https://glp1nutrition.org/apps/macrofactor-glp1-review/MacroFactor's adaptive-target algorithm handles the moving target of decreasing maintenance calories during GLP-1 weight loss well. No dedicated GLP-1 mode and no permanent free tier are the main limitations.Sun, 08 Mar 2026 00:00:00 GMTMacroFactorGLP-1 macrosadaptive calorie target GLP-1MacroFactor semaglutideMacroFactor tirzepatidemacro tracker GLP-1https://glp1nutrition.org/protein/tracking-protein-when-you-eat-less/https://glp1nutrition.org/protein/tracking-protein-when-you-eat-less/Why traditional typed food logs become unreliable on GLP-1, and why photo-first logging fits the smaller-meal pattern. Practical comparison with manual tracking. Brief audit periods as an alternative.Sun, 08 Mar 2026 00:00:00 GMTGLP-1 food trackingGLP-1 photo loggingGLP-1 protein trackingWegovy food logOzempic tracking appsmaller meals trackinghttps://glp1nutrition.org/muscle-mass/tracking-muscle-mass-changes/https://glp1nutrition.org/muscle-mass/tracking-muscle-mass-changes/A practical follow-up framework for tracking muscle-mass changes on GLP-1: body-composition measurement (DXA or BIA), functional measures (grip strength, chair-stand), engagement metrics (protein intake adequacy, resistance-training frequency), and how to interpret the trend with the clinician.Sun, 08 Mar 2026 00:00:00 GMTGLP-1 muscle mass trackingWegovy lean mass trackingOzempic body composition follow uptirzepatide muscle preservationGLP-1 strength trackinghttps://glp1nutrition.org/side-effects/gastroparesis-and-glp-1-considerations/https://glp1nutrition.org/side-effects/gastroparesis-and-glp-1-considerations/Gastroparesis (delayed gastric emptying) and GLP-1 medications interact in clinically meaningful ways. This article discusses what the published literature describes, what symptoms warrant clinical evaluation, and why nutritional self-management is not appropriate for suspected gastroparesis.Wed, 04 Mar 2026 00:00:00 GMTGLP-1 gastroparesissemaglutide gastroparesisOzempic gastroparesisWegovy gastroparesistirzepatide gastric emptyingGLP-1 stomach paralysishttps://glp1nutrition.org/apps/lose-it-glp1-review/https://glp1nutrition.org/apps/lose-it-glp1-review/Lose It! is a beginner-friendly calorie tracker with a clean interface and a substantial food database. It is a defensible starter pick for patients new to tracking but is thin on the GLP-1-relevant axes — no dedicated GLP-1 mode, limited micronutrient depth, no clinician-grade workflow.Mon, 02 Mar 2026 00:00:00 GMTLose It!GLP-1 beginner trackerLose It WegovyLose It OzempicGLP-1 starter apphttps://glp1nutrition.org/protein/protein-meal-replacement-shakes-glp-1/https://glp1nutrition.org/protein/protein-meal-replacement-shakes-glp-1/Liquid protein and meal-replacement shakes on GLP-1 receptor agonist therapy. What to look for in a quality shake. Whey, casein, plant-protein isolate options. Tolerance considerations. Common product categories.Sun, 01 Mar 2026 00:00:00 GMTGLP-1 protein shakeWegovy protein shakeOzempic protein shakeGLP-1 meal replacementtirzepatide shakebest protein shake GLP-1https://glp1nutrition.org/muscle-mass/older-adults-on-glp-1-sarcopenia-risk/https://glp1nutrition.org/muscle-mass/older-adults-on-glp-1-sarcopenia-risk/GLP-1 use in older adults is increasing. Higher baseline sarcopenia risk, anabolic resistance, and the consequences of lean-mass loss in this population. Higher protein targets and resistance-training engagement matter more here than in younger patients.Sun, 01 Mar 2026 00:00:00 GMTolder adults GLP-1GLP-1 sarcopeniaelderly Wegovyelderly OzempicGLP-1 65+sarcopenia GLP-1 proteinhttps://glp1nutrition.org/protein/protein-quality-and-leucine-thresholds/https://glp1nutrition.org/protein/protein-quality-and-leucine-thresholds/Per-meal leucine threshold of approximately 2.5-3 g is the threshold for stimulating muscle protein synthesis. How different protein sources reach (or do not reach) this threshold at different per-meal portions. Practical implications for GLP-1 patients with reduced meal capacity.Sat, 28 Feb 2026 00:00:00 GMTleucine threshold GLP-1protein quality GLP-1muscle protein synthesis GLP-1leucine Wegovycomplete protein GLP-1https://glp1nutrition.org/side-effects/dehydration-and-electrolyte-attention/https://glp1nutrition.org/side-effects/dehydration-and-electrolyte-attention/Why dehydration is a real risk on GLP-1 even without obvious symptoms. Structured fluid patterns. Electrolyte considerations: sodium, potassium, magnesium. When laboratory monitoring matters.Thu, 26 Feb 2026 00:00:00 GMTGLP-1 dehydrationWegovy hydrationOzempic dehydrationtirzepatide electrolytesGLP-1 fluid intakeGLP-1 electrolytehttps://glp1nutrition.org/medications/tirzepatide-mounjaro-zepbound-nutrition/https://glp1nutrition.org/medications/tirzepatide-mounjaro-zepbound-nutrition/How tirzepatide nutritionally compares with semaglutide. SURMOUNT body-composition findings. Protein, side-effect, hydration, and micronutrient considerations specific to the dual-agonist mechanism.Wed, 25 Feb 2026 00:00:00 GMTtirzepatide nutritionMounjaro nutritionZepbound nutritionMounjaro proteinZepbound proteintirzepatide diettirzepatide GLP-1 GIPhttps://glp1nutrition.org/protein/protein-pacing-when-appetite-is-low/https://glp1nutrition.org/protein/protein-pacing-when-appetite-is-low/Distribution of protein across the day matters for muscle protein synthesis stimulation. Practical pacing patterns when meal capacity is reduced. Bedtime protein. Front-loading vs even-distribution. Worked examples.Sun, 22 Feb 2026 00:00:00 GMTprotein pacing GLP-1GLP-1 meal frequencyGLP-1 protein distributionWegovy protein mealsOzempic small meals proteinhttps://glp1nutrition.org/muscle-mass/dexa-and-other-body-composition-tools/https://glp1nutrition.org/muscle-mass/dexa-and-other-body-composition-tools/DXA scans, MRI, bioelectrical impedance (BIA), and anthropometric methods for body-composition tracking on GLP-1. What each measures, what the limitations are, and how to integrate body-composition follow-up with clinical care.Sun, 22 Feb 2026 00:00:00 GMTDXA scan GLP-1GLP-1 body compositionInBody GLP-1bioelectrical impedance GLP-1GLP-1 lean mass measurementWegovy DXAhttps://glp1nutrition.org/side-effects/constipation-fiber-strategies/https://glp1nutrition.org/side-effects/constipation-fiber-strategies/Why GLP-1 medications commonly cause constipation. Graduated fiber strategies. Fluid adequacy. Considered use of osmotic agents (with clinician input). When constipation requires clinical evaluation rather than self-management.Thu, 19 Feb 2026 00:00:00 GMTGLP-1 constipationWegovy constipationOzempic constipationtirzepatide constipationGLP-1 fiberGLP-1 bowelhttps://glp1nutrition.org/research/long-term-glp-1-discontinuation-rebound/https://glp1nutrition.org/research/long-term-glp-1-discontinuation-rebound/STEP-1 Extension trial (Wilding et al., 2022) and SURMOUNT-4 (Aronne et al., 2024) are the most-cited evidence for weight regain after GLP-1 receptor agonist discontinuation. Magnitude of regain. Clinical framing of GLP-1 therapy as long-term. Nutritional implications during and after discontinuation.Thu, 19 Feb 2026 00:00:00 GMTGLP-1 discontinuationWegovy stoppingOzempic stoppingtirzepatide discontinuationGLP-1 rebound weight gainGLP-1 long-termhttps://glp1nutrition.org/medications/dulaglutide-trulicity-nutrition/https://glp1nutrition.org/medications/dulaglutide-trulicity-nutrition/Dulaglutide (Trulicity) is FDA-approved for Type 2 diabetes only, not for chronic weight management. Weight loss is typically smaller than with semaglutide or tirzepatide. Practical nutritional considerations for diabetes-focused GLP-1 use.Wed, 18 Feb 2026 00:00:00 GMTdulaglutide nutritionTrulicity nutritionTrulicity proteinTrulicity dietdulaglutide diabetes diethttps://glp1nutrition.org/protein/whey-vs-plant-protein-on-glp-1/https://glp1nutrition.org/protein/whey-vs-plant-protein-on-glp-1/Whey, casein, and other animal proteins versus pea, soy, rice, hemp, and other plant proteins on GLP-1. Completeness, leucine content, digestibility, satiety implications, and practical considerations for patients with smaller meal capacity.Sun, 15 Feb 2026 00:00:00 GMTwhey protein GLP-1plant protein GLP-1Wegovy plant proteinOzempic vegetarian proteinGLP-1 protein qualityleucine GLP-1https://glp1nutrition.org/muscle-mass/resistance-training-while-on-glp-1/https://glp1nutrition.org/muscle-mass/resistance-training-while-on-glp-1/What 'resistance training' actually means in the muscle-preservation context. Practical programming for GLP-1 patients: 2-3 sessions per week, progressive, covering major muscle groups. Considerations for reduced energy availability, dose-day timing, and training tolerance.Sun, 15 Feb 2026 00:00:00 GMTGLP-1 resistance trainingWegovy strength trainingOzempic strength trainingtirzepatide weight trainingGLP-1 lean mass exerciseGLP-1 gymhttps://glp1nutrition.org/medications/semaglutide-ozempic-wegovy-nutrition/https://glp1nutrition.org/medications/semaglutide-ozempic-wegovy-nutrition/What changes nutritionally when a patient is initiated and titrated on once-weekly semaglutide. Protein adequacy, side-effect-driven undereating, micronutrient considerations, hydration patterns, and the practical questions patients commonly bring to a dietitian appointment in the first 6-12 months.Thu, 12 Feb 2026 00:00:00 GMTsemaglutide nutritionOzempic nutritionWegovy nutritionOzempic proteinWegovy proteinsemaglutide dietGLP-1 nutrition guidehttps://glp1nutrition.org/side-effects/early-satiety-and-nutrient-density/https://glp1nutrition.org/side-effects/early-satiety-and-nutrient-density/When meal capacity is reduced, what goes into each meal matters more. Practical nutrient-density strategies: protein first, micronutrient-dense plates, liquid-protein options when whole-food capacity is the limit.Thu, 12 Feb 2026 00:00:00 GMTGLP-1 early satietyWegovy early satietysmall meals GLP-1nutrient density GLP-1tirzepatide small mealsprotein first GLP-1https://glp1nutrition.org/research/protein-and-resistance-training-meta-analysis/https://glp1nutrition.org/research/protein-and-resistance-training-meta-analysis/The Sardeli et al. 2018 meta-analysis on resistance training during caloric restriction in obese elderly individuals. The broader literature on protein adequacy under hypocaloric conditions. Translation of pre-GLP-1-era findings to GLP-1-era practice.Thu, 12 Feb 2026 00:00:00 GMTprotein resistance training meta-analysisGLP-1 muscle preservation evidencehypocaloric resistance trainingSardeli meta-analysislean mass preservation evidencehttps://glp1nutrition.org/medications/liraglutide-saxenda-victoza-nutrition/https://glp1nutrition.org/medications/liraglutide-saxenda-victoza-nutrition/Liraglutide is a once-daily GLP-1 receptor agonist with a longer clinical track record but typically smaller weight-loss magnitude than semaglutide or tirzepatide. Practical nutritional considerations for daily-injection rhythm, side-effect timing, and protein/micronutrient adequacy.Sun, 08 Feb 2026 00:00:00 GMTliraglutide nutritionSaxenda nutritionVictoza nutritionSaxenda proteinSaxenda dietliraglutide diethttps://glp1nutrition.org/muscle-mass/lean-mass-loss-on-glp-1-the-evidence/https://glp1nutrition.org/muscle-mass/lean-mass-loss-on-glp-1-the-evidence/What the published trial body-composition substudies show about lean-mass loss on semaglutide and tirzepatide. The 25-40% range. Variability across studies. Known mitigations: protein adequacy and resistance training. Hedged interpretation for clinical practice.Sun, 08 Feb 2026 00:00:00 GMTGLP-1 muscle lossWegovy muscle lossOzempic muscle losstirzepatide lean masssemaglutide lean massGLP-1 sarcopeniaSTEP body compositionhttps://glp1nutrition.org/side-effects/nausea-what-to-eat/https://glp1nutrition.org/side-effects/nausea-what-to-eat/Nutritional strategies that may reduce GLP-1-related nausea: smaller, more frequent, lower-fat meals; cool foods; ginger; structured hydration. When nausea exceeds the threshold for self-management. What to discuss with your clinician.Thu, 05 Feb 2026 00:00:00 GMTGLP-1 nauseaWegovy nauseaOzempic nausea what to eattirzepatide nausea foodMounjaro nausea dietnausea GLP-1 gingerhttps://glp1nutrition.org/medications/oral-semaglutide-rybelsus-nutrition/https://glp1nutrition.org/medications/oral-semaglutide-rybelsus-nutrition/Once-daily oral semaglutide (Rybelsus) is FDA-approved for Type 2 diabetes. The medication's absorption is highly food-dependent and requires strict morning fasting around the dose. This article covers the timing requirement, side effects, and nutritional planning.Wed, 04 Feb 2026 00:00:00 GMTRybelsus nutritionoral semaglutideRybelsus food timingRybelsus dietoral GLP-1 nutritionhttps://glp1nutrition.org/protein/protein-targets-on-glp-1/https://glp1nutrition.org/protein/protein-targets-on-glp-1/Practical starting protein-target ranges for adults under hypocaloric conditions on GLP-1 receptor agonist therapy, with explicit caveats. Older-adult considerations. Resistance-training context. Renal-disease caveats. The keystone article on protein for GLP-1 patients.Fri, 30 Jan 2026 00:00:00 GMTprotein on GLP-1GLP-1 protein targethow much protein on Ozempichow much protein on Wegovyprotein on tirzepatideGLP-1 muscle mass proteinhttps://glp1nutrition.org/research/surmount-trials-tirzepatide-2026/https://glp1nutrition.org/research/surmount-trials-tirzepatide-2026/SURMOUNT-1 (Jastreboff 2022, NEJM), SURMOUNT-2 (Garvey 2023, The Lancet), SURMOUNT-3 (Wadden 2023, Nature Medicine), and the body-composition findings from the trial program. Comparable lean-mass-loss proportions to STEP, with larger absolute weight loss.Thu, 29 Jan 2026 00:00:00 GMTSURMOUNT trial tirzepatideZepbound clinical trialSURMOUNT-1 NEJMtirzepatide body compositiontirzepatide weight loss trialhttps://glp1nutrition.org/research/step-trials-overview-2026/https://glp1nutrition.org/research/step-trials-overview-2026/The STEP trials (STEP-1, STEP-2, STEP-3, STEP-5, STEP-8) established the efficacy of semaglutide 2.4 mg weekly for chronic weight management. This article summarises the key findings with a focus on the body-composition substudy data relevant to lean-mass preservation.Thu, 22 Jan 2026 00:00:00 GMTSTEP trials semaglutideSTEP-1 NEJMWegovy clinical trialsemaglutide body compositionsemaglutide weight loss trial